Tag: IGHMBP2

• The “First Treatable CMT Disease” is Neither CMT Nor a Disease

  

  CMT-related research may truly do away with CMT disease first by eliminating or updating how naming and classification works in neurological pathology.

  Dan

  February 28, 2023

  News, Research

  Applied Therapeutics, AT-007, CMT2S, CMTA, CoQ10, COQ7, HNF, IGHMBP2, MD Canada, Neuromuscular Disorders, NMD4C, SMARD1, SORD